0.692
price down icon7.00%   -0.0521
after-market After Hours: .70 0.008 +1.16%
loading

Cytomx Therapeutics Inc Stock (CTMX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
55.83%
41.46
26.61 26.38 24.72 23.50
Operating Expenses
9.53%
29.81
27.21 23.26 28.07 29.15
Benefits Costs and Expenses
11.83%
27.62
24.70 20.57 - 26.81
Costs And Expenses
11.83%
27.62
24.70 20.57 28.07 26.81
Operating Income/Loss
2,024%
11.66
-0.606 3.123 -3.348 -5.653
Income/Loss From Continuing Operations Before Tax
626.13%
13.84
1.906 5.815 -1.087 -3.311
Income Tax Expense/Benefit
95.42%
0.049
1.069 2.823 - -
Income/Loss From Continuing Operations After Tax
1,548%
13.79
0.837 2.992 -1.087 -3.311
Net Income/Loss
1,548%
13.79
0.837 2.992 -1.087 -3.311
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,076%
82.03
2.5828 80.73 66.54 66.25
Diluted Average Shares
3,099%
82.63
2.5828 80.99 66.54 66.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):